Abiraterone and enzalutamide are now listed in the interaction checker as cancer drugs and interactions can be found for all the comedications.
• Abiraterone (Zytiga®) is an androgen biosynthesis inhibitor and is indicated for the treatment of prostatic neoplasms.
• Enzalutamide (Xtandi®) is an androgen receptor inhibitor and is indicated for the treatment of prostatic neoplasms.
